JD, B., S, D., CM, C., A, M., K, T., A, V., . . . L, P. (2024). Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood advances, 8(15), 4164. https://doi.org/10.1182/bloodadvances.2024012928
Chicago Style (17th ed.) CitationJD, Bender, et al. "Real-world Use of Tisagenlecleucel in Children and Young Adults with Relapsed or Refractory B-cell Lymphomas." Blood Advances 8, no. 15 (2024): 4164. https://doi.org/10.1182/bloodadvances.2024012928.
MLA (9th ed.) CitationJD, Bender, et al. "Real-world Use of Tisagenlecleucel in Children and Young Adults with Relapsed or Refractory B-cell Lymphomas." Blood Advances, vol. 8, no. 15, 2024, p. 4164, https://doi.org/10.1182/bloodadvances.2024012928.
Warning: These citations may not always be 100% accurate.
